PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
9.20
-0.08 (-0.86%)
At close: Apr 14, 2026, 4:00 PM EDT
9.16
-0.04 (-0.43%)
After-hours: Apr 14, 2026, 4:04 PM EDT
PAVmed Revenue
In the year 2025, PAVmed had annual revenue of $71.00K, down -97.63%. PAVmed had revenue of $52.00K in the quarter ending December 31, 2025, with 420.00% growth.
Revenue (ttm)
$71.00K
Revenue Growth
-97.63%
P/S Ratio
809.43
Revenue / Employee
$1,732
Employees
41
Market Cap
58.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 71.00K | -2.92M | -97.63% |
| Dec 31, 2024 | 3.00M | 543.00K | 22.15% |
| Dec 31, 2023 | 2.45M | 2.08M | 550.40% |
| Dec 31, 2022 | 377.00K | -123.00K | -24.60% |
| Dec 31, 2021 | 500.00K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xtant Medical Holdings | 133.93M |
| Pulmonx | 90.50M |
| LENSAR | 58.44M |
| electroCore | 32.03M |
| Baird Medical Investment Holdings | 31.86M |
| Spectral AI | 19.65M |
| Elutia | 12.29M |
| InspireMD | 8.98M |
PAVM News
- 5 days ago - Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 12 days ago - PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio - PRNewsWire
- 15 days ago - PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 19 days ago - Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 4 weeks ago - PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026 - PRNewsWire
- 4 weeks ago - Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 - PRNewsWire
- 2 months ago - PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities - PRNewsWire
- 2 months ago - Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? - Invezz